SulNOx Group PLC - Change of Adviser
RNS Number : 3733X
SulNOx Group PLC
28 August 2020
 

28 August 2020

SulNOx Group Plc (the "Company" or "SulNOx")

 Change of Adviser

 

(Aquis Stock Exchange: SNOX)

SulNOx is pleased to announce the appointment of Allenby Capital Limited ("Allenby") as the Company's AQSE Growth Market Corporate Adviser with immediate effect.

Nicholas Nelson, Chief Executive, commented:

 "With over 8 months under our belt as a listed company, we are delighted to become a client of Allenby which has a strong reputation in the City as a leading stockbroking and corporate advisory firm.

"We thank Alexander David Securities for the excellent service it has provided to the Company since early 2019 in guiding us through to a listing on the Aquis Stock Exchange."

 

Enquiries:

SulNOx Group Plc

Nicholas Nelson, Chief Executive

 

sulnox@flagstaffcomms.com

 

Media and Investors:

Flagstaff Strategic and Investor Communications

Tim Thompson / Fergus Mellon

 

sulnox@flagstaffcomms.com

020 7129 1474

 

Aquis Stock Exchange Corporate Adviser:

Allenby Capital Limited

John Depasquale / James Hornigold

 

 020 3328 5656

 

The directors take responsibility for this announcement.

About SulNOx Group Plc

SulNOx, www.sulnoxgroup.com , has developed a hydrocarbon fuels conditioning and emulsifying process which enables more efficient fuel combustion, potentially leading to reduced fuel consumption and significantly lowered emissions.

 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFLFIETFIDFII ]]>